| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-30 16:45:11 UTC |
|---|
| Updated at | 2022-05-30 16:45:11 UTC |
|---|
| NP-MRD ID | NP0137207 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Calicheamicin |
|---|
| Description | Calicheamicin belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Calicheamicin was first documented in 2021 (PMID: 34441852). Based on a literature review a small amount of articles have been published on Calicheamicin (PMID: 35468945) (PMID: 35290067) (PMID: 34297027) (PMID: 34155147). |
|---|
| Structure | CCNC1COC(CC1OC)OC1C(O)C(NOC2CC(O)C(SC(=O)C3=C(C)C(I)=C(OC4OC(C)C(O)C(OC)C4O)C(OC)=C3OC)C(C)O2)C(C)OC1OC1C#CC=CC#CC2(O)CC(=O)C(NC(=O)OC)=C1C2=CCSSSC InChI=1S/C55H74IN3O21S4/c1-12-57-30-24-73-35(22-34(30)68-6)78-48-43(63)40(26(3)75-53(48)77-33-17-15-13-14-16-19-55(67)23-32(61)41(58-54(66)72-10)38(33)29(55)18-20-82-84-81-11)59-80-36-21-31(60)50(28(5)74-36)83-51(65)37-25(2)39(56)46(49(71-9)45(37)69-7)79-52-44(64)47(70-8)42(62)27(4)76-52/h13-14,18,26-28,30-31,33-36,40,42-44,47-48,50,52-53,57,59-60,62-64,67H,12,20-24H2,1-11H3,(H,58,66) |
|---|
| Synonyms | | Value | Source |
|---|
| Calicheamicins | HMDB | | Calicheamicin gamma(1)I | HMDB | | Calichemicin gamma1 | HMDB | | N-{8-[(5-{[(5-{4-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoylsulfanyl}-4-hydroxy-6-methyloxan-2-yl)oxy]amino}-3-{[5-(ethylamino)-4-methoxyoxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-13-{2-[(methylsulfanyl)disulfanyl]ethylidene}-11-oxobicyclo[7.3.1]trideca-4,9-dien-2,6-diyn-10-yl}methoxycarboximidate | HMDB | | N-{8-[(5-{[(5-{4-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoylsulphanyl}-4-hydroxy-6-methyloxan-2-yl)oxy]amino}-3-{[5-(ethylamino)-4-methoxyoxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-13-{2-[(methylsulphanyl)disulphanyl]ethylidene}-11-oxobicyclo[7.3.1]trideca-4,9-dien-2,6-diyn-10-yl}methoxycarboximidate | HMDB | | N-{8-[(5-{[(5-{4-[(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoylsulphanyl}-4-hydroxy-6-methyloxan-2-yl)oxy]amino}-3-{[5-(ethylamino)-4-methoxyoxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-13-{2-[(methylsulphanyl)disulphanyl]ethylidene}-11-oxobicyclo[7.3.1]trideca-4,9-dien-2,6-diyn-10-yl}methoxycarboximidic acid | HMDB |
|
|---|
| Chemical Formula | C55H74IN3O21S4 |
|---|
| Average Mass | 1368.3400 Da |
|---|
| Monoisotopic Mass | 1367.27424 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCNC1COC(CC1OC)OC1C(O)C(NOC2CC(O)C(SC(=O)C3=C(C)C(I)=C(OC4OC(C)C(O)C(OC)C4O)C(OC)=C3OC)C(C)O2)C(C)OC1OC1C#CC=CC#CC2(O)CC(=O)C(NC(=O)OC)=C1C2=CCSSSC |
|---|
| InChI Identifier | InChI=1S/C55H74IN3O21S4/c1-12-57-30-24-73-35(22-34(30)68-6)78-48-43(63)40(26(3)75-53(48)77-33-17-15-13-14-16-19-55(67)23-32(61)41(58-54(66)72-10)38(33)29(55)18-20-82-84-81-11)59-80-36-21-31(60)50(28(5)74-36)83-51(65)37-25(2)39(56)46(49(71-9)45(37)69-7)79-52-44(64)47(70-8)42(62)27(4)76-52/h13-14,18,26-28,30-31,33-36,40,42-44,47-48,50,52-53,57,59-60,62-64,67H,12,20-24H2,1-11H3,(H,58,66) |
|---|
| InChI Key | HXCHCVDVKSCDHU-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Phenolic glycosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenolic glycoside
- O-glycosyl compound
- Halobenzoic acid or derivatives
- 3-halobenzoic acid or derivatives
- Dimethoxybenzene
- O-dimethoxybenzene
- Thiobenzoic acid or derivatives
- Benzoic acid or derivatives
- Anisole
- Phenoxy compound
- Phenol ether
- Benzoyl
- Methoxybenzene
- Toluene
- Cyclohexenone
- Halobenzene
- Alkyl aryl ether
- Iodobenzene
- Aryl halide
- Aryl iodide
- Monocyclic benzene moiety
- Monosaccharide
- Oxane
- Ynone
- Benzenoid
- Methylcarbamate
- Tertiary alcohol
- Organic trisulfide
- Carbamic acid ester
- Ketone
- Thiocarboxylic acid ester
- Carbonic acid derivative
- Carbothioic s-ester
- Secondary alcohol
- Cyclic ketone
- Amino acid or derivatives
- Dialkyl ether
- N-organohydroxylamine
- Carboxylic acid derivative
- Thiocarboxylic acid or derivatives
- Secondary aliphatic amine
- Secondary amine
- Ether
- Acetal
- Sulfenyl compound
- Oxacycle
- Organoheterocyclic compound
- Organosulfur compound
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Alcohol
- Hydrocarbon derivative
- Amine
- Organohalogen compound
- Organoiodide
- Organic nitrogen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Pennesi E, Michels N, Brivio E, van der Velden VHJ, Jiang Y, Thano A, Ammerlaan AJC, Boer JM, Beverloo HB, Sleight B, Chen Y, Vormoor-Burger B, Rives S, Bielorai B, Rossig C, Petit A, Rizzari C, Engstler G, Stary J, Bautista Sirvent FJ, Chen-Santel C, Bruno B, Bertrand Y, Rialland F, Plat G, Reinhardt D, Vinti L, Von Stackelberg A, Locatelli F, Zwaan CM: Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial. Leukemia. 2022 Jun;36(6):1516-1524. doi: 10.1038/s41375-022-01576-3. Epub 2022 Apr 25. [PubMed:35468945 ]
- Feng X, Liu H, Pan J, Xiong Y, Zhu X, Yan X, Duan Y, Huang Y: Liposome-Encapsulated Tiancimycin A Is Active against Melanoma and Metastatic Breast Tumors: The Effect of cRGD Modification of the Liposomal Carrier and Tiancimycin A Dose on Drug Activity and Toxicity. Mol Pharm. 2022 Apr 4;19(4):1078-1090. doi: 10.1021/acs.molpharmaceut.1c00753. Epub 2022 Mar 15. [PubMed:35290067 ]
- Stokke JL, Bhojwani D: Antibody-Drug Conjugates for the Treatment of Acute Pediatric Leukemia. J Clin Med. 2021 Aug 13;10(16). pii: jcm10163556. doi: 10.3390/jcm10163556. [PubMed:34441852 ]
- Mills A, Gago F: Structural and mechanistic insight into DNA bending by antitumour calicheamicins. Org Biomol Chem. 2021 Aug 5;19(30):6707-6717. doi: 10.1039/d1ob01077h. [PubMed:34297027 ]
- Nicolaou KC, Rigol S, Pitsinos EN, Das D, Lu Y, Rout S, Schammel AW, Holte D, Lin B, Gu C, Sarvaiya H, Trinidad J, Barbour N, Valdiosera AM, Sandoval J, Lee C, Aujay M, Fernando H, Dhar A, Karsunky H, Taylor N, Pysz M, Gavrilyuk J: Uncialamycin-based antibody-drug conjugates: Unique enediyne ADCs exhibiting bystander killing effect. Proc Natl Acad Sci U S A. 2021 Jun 22;118(25). pii: 2107042118. doi: 10.1073/pnas.2107042118. [PubMed:34155147 ]
|
|---|